Search
Search Results
##search.searchResults.foundPlural##
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1488PDF: 768HTML: 203 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2838PDF: 847HTML: 6518Untitled: 226Untitled: 189Untitled: 203Untitled: 210 -
Osteolytic bone lesions – A rare presentation of AML M6.
1971PDF: 1095HTML: 7936Untitled: 203 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9051PDF: 6057HTML: 87956Fig.1b: 184Fig.1c: 188Fig.2a: 176Fig.2b: 175Fig.4: 188Fig.2c: 183Fig.3: 181Tab.1: 225Tab.2: 206Tab.3: 188Tab.4: 220Fig1a: 181 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2190PDF: 928HTML: 409Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 213UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 341Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 240Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 176Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 188Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 257 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1755PDF: 570HTML: 282 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
2836PDF: 966HTML: 3128flowcytometric result of peripheral blood sample: 179 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4297PDF: 1372HTML: 2039 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1265PDF: 484HTML: 137 -
-
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2267PDF: 933HTML: 301 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1658PDF: 747HTML: 247 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3510PDF: 881HTML: 1653figure 1: 165Untitled: 188 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2202PDF: 945HTML: 5063Cover Letter: 169Figure 2: 160Figure 1: 173Figure 3: 195Figure 4: 166Figure Legend: 186Table 1: 188Table 2: 180Table 3: 179 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4313PDF: 1488HTML: 1547Untitled: 225 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1719PDF: 769HTML: 504 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2192PDF: 1487HTML: 266 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
852PDF: 601HTML: 108 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2015PDF: 758HTML: 3113 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1101PDF: 542HTML: 1690Figures: 167Fifures Sanz: 176tables Sanz: 180Untitled: 176 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1237PDF: 756HTML: 314 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1451PDF: 906HTML: 2211Response to reviewers comments: 180 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2775PDF: 1812HTML: 3666Pellagatti Fig 1: 214Pellagatti Fig. 2: 210 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
477PDF: 243HTML: 78 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1417PDF: 901Suppl. Files: 454HTML: 235 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2686PDF: 764HTML: 219







